Exscientia to highlight precision medicine platform and pipeline data at the american association of cancer research annual meeting 2022

Oxford, england--(business wire)--exscientia (nasdaq: exai) today announced the acceptance of three abstracts for poster presentation at the upcoming american association for cancer research (aacr) annual meeting 2022, being held april 8-13, 2022, at the ernest n. morial convention center in new orleans, la. “the abstracts highlighted at aacr demonstrate the potential of our functional precision oncology tools to improve clinical and patient outcomes by guiding treatment and patient selection u
EXAI Ratings Summary
EXAI Quant Ranking